Lin Yu-Hsin

Chief Executive Officer, DirectorBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Aug 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$66K
Net Open-Market Flow
-$66K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2026Sell(S)142$180.00$26K171K
Aug 12, 2026Sell(S)223$180.57$40K171K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-350217) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.